Esserman L - Search Results

1

The effect of sentinel node tumor burden on non-sentinel node status and recurrence rates in breast cancer.

Fan YG, Tan YY, Wu CT, Treseler P, Lu Y, Chan CW, Hwang S, Ewing C, Esserman L, Morita E, Leong SP. Fan YG, et al. Among authors: esserman l. Ann Surg Oncol. 2005 Sep;12(9):705-11. doi: 10.1245/ASO.2005.08.020. Epub 2005 Aug 4. Ann Surg Oncol. 2005. PMID: 16079953

2

Current national health insurance coverage policies for breast and ovarian cancer prophylactic surgery.

Kuerer HM, Hwang ES, Anthony JP, Dudley RA, Crawford B, Aubry WM, Esserman LJ. Kuerer HM, et al. Among authors: esserman lj. Ann Surg Oncol. 2000 Jun;7(5):325-32. doi: 10.1007/s10434-000-0325-1. Ann Surg Oncol. 2000. PMID: 10864338

3

Integration of breast imaging into cancer management.

Esserman LJ, Wolverton D, Hylton N. Esserman LJ, et al. Curr Oncol Rep. 2000 Nov;2(6):572-81. doi: 10.1007/s11912-000-0112-y. Curr Oncol Rep. 2000. PMID: 11122895 Review.

4

Skin-sparing mastectomy and immediate breast reconstruction: a prospective cohort study for the treatment of advanced stages of breast carcinoma.

Foster RD, Esserman LJ, Anthony JP, Hwang ES, Do H. Foster RD, et al. Ann Surg Oncol. 2002 Jun;9(5):462-6. doi: 10.1007/BF02557269. Ann Surg Oncol. 2002. PMID: 12052757

5

Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy.

Partridge SC, Gibbs JE, Lu Y, Esserman LJ, Sudilovsky D, Hylton NM. Partridge SC, et al. AJR Am J Roentgenol. 2002 Nov;179(5):1193-9. doi: 10.2214/ajr.179.5.1791193. AJR Am J Roentgenol. 2002. PMID: 12388497

6

Failure to harvest sentinel lymph nodes identified by preoperative lymphoscintigraphy in breast cancer patients.

Wu CT, Morita ET, Treseler PA, Esserman LJ, Hwang ES, Kuerer HM, Santos CL, Leong SP. Wu CT, et al. Among authors: esserman lj. Breast J. 2003 Mar-Apr;9(2):86-90. doi: 10.1046/j.1524-4741.2003.09205.x. Breast J. 2003. PMID: 12603380

7

Magnetic resonance imaging in patients diagnosed with ductal carcinoma-in-situ: value in the diagnosis of residual disease, occult invasion, and multicentricity.

Hwang ES, Kinkel K, Esserman LJ, Lu Y, Weidner N, Hylton NM. Hwang ES, et al. Ann Surg Oncol. 2003 May;10(4):381-8. doi: 10.1245/aso.2003.03.085. Ann Surg Oncol. 2003. PMID: 12734086

8

Neoadjuvant chemotherapy for primary breast cancer: lessons learned and opportunities to optimize therapy.

Esserman L. Esserman L. Ann Surg Oncol. 2004 Jan;11(1 Suppl):3S-8S. doi: 10.1007/BF02524789. Ann Surg Oncol. 2004. PMID: 15015703 Review. No abstract available.

9

Neoadjuvant hormonal therapy for ductal carcinoma in situ: trial design and preliminary results.

Hwang ES, Esserman L. Hwang ES, et al. Among authors: esserman l. Ann Surg Oncol. 2004 Jan;11(1 Suppl):37S-43S. doi: 10.1007/BF02524794. Ann Surg Oncol. 2004. PMID: 15015708

10

Accuracy of selective sentinel lymphadenectomy after neoadjuvant chemotherapy: effect of clinical node status at presentation.

Lang JE, Esserman LJ, Ewing CA, Rugo HS, Lane KT, Leong SP, Hwang ES. Lang JE, et al. J Am Coll Surg. 2004 Dec;199(6):856-62. doi: 10.1016/j.jamcollsurg.2004.08.023. J Am Coll Surg. 2004. PMID: 15555967

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

489 results

Search Page

Filters